Key points are not available for this paper at this time.
This article reviews the risks of osteoporosis and osteonecrosis associated with glucocorticoid use, which are present even in the absence of low bone mineral density, and discusses strategies to reduce the risk of fractures and the data to support the strategies.
Robert S. Weinstein (2011) studied this question.